Elasty d plus filler3/13/2023 Results: The HA appears as a hypoechoic image within the soft tissue plane on HRUS. Ultrasonographic evaluation (Logiq p6 GE Healthcare, Waukesha, Washington) was performed before and immediately after HA filler injection. Half of the patients (n = 5) were treated with Restylane-L (Medicis Aesthetics, Inc, Scottsdale, Arizona) and the remaining 5 with Belotero Balance (Merz Aesthetics, Inc, San Mateo, California). Methods: The charts of 10 patients who underwent periocular injection using HA gel filler and were subsequently examined with HRUS were reviewed. Objectives: The authors investigate the difference in the distribution pattern between 2 HA fillers in the periocular tissue using HRUS. It also allows visualization of hyaluronic acid (HA) gel within the soft tissue. All rights reserved.īackground: High-resolution ultrasound (HRUS) is a useful tool in defining anatomic and dynamic soft tissue relationships in the periocular area. © 2018 Journal of Clinical and Aesthetic Dermatology. Three illustrative cases are also presented. Here, the author presents a 12-point revitalization guide, based on personal experience, as an approach for the pan-facial application of calcium hydroxylapatite and hyaluronic acid fillers specific to the aging female face that can result in an understated and age-appropriate appearance. Mature women might prefer subtler corrections that do not significantly alter their faces, but rather refresh and revitalize their current appearance. These existing principles do not necessarily translate well to an older face due to underlying facial skeletal changes associated with aging. This unsatisfactory outcome in older women might be due to the inappropriate application of filler enhancement principles that are based the characteristics of a young face. These interventions are performed in both younger and older women and can result in exaggerated or over-augmented lips and cheeks. Soft tissue filler augmentation for beautification is a common aesthetic request from women who wish to enhance facial features. Thus, GFC therapy can be a safe, effective, and new option in the armamentarium of melasma management. Significant improvement in melasma was observed with GFC monotherapy, which needs further confirmation in larger randomized controlled studies. Side effects reported were mild such as injection site pain, erythema, oedema and bruising, and resolved spontaneously within a few hours to few days of onset. Overall, aesthetic improvement was reported in 88.5% of subjects. Significant improvement in mean mMASI score was seen in subjects who had mild to moderate melasma at baseline (P < 0.05). Totally, 66.7% of severe melasma subjects showed improvement to mild to moderate category. ![]() Statistically significant decrease in the mean mMASI scores was observed at all visits compared to baseline (P < 0.005 for each visit). Out of 40 subjects enrolled, 30 subjects completed three GFC sessions and 26, completed day 90 follow-up. Total three sessions of GFC monotherapy were given with one-month interval (day 0, day 30, and day 60) and follow up of subjects was done at day 90 for the final clinical assessment. Subjects of Fitzpatrick skin type IV-V, of either gender, more than equal to 18 years of age, with a clinical diagnosis of melasma were enrolled in the study. Currently, there are various treatment options available but none is effective universally.Īssess the role of Yuskin®, a growth factor concentrate (GFC) therapy, a modified platelet rich plasma (PRP) technique for the treatment of melasma. Melasma is a common acquired pigmentary skin disorder. Conclusions The study confirms the good performance and safety of SFP for a range of facial indications in routine clinical practice. Moreover, a significant correlation was found, by analyzing the grade of facial aging, calculated by using the WSRS or the lifestyle of the patients (smokers or non-smokers) in relation to the cosmetic effects of the treatment. Results Statistical analysis showed a significant effect on facial aging for all the SFP fillers used at all time-points studied. Analyses of the cosmetic effects were performed by using the Wrinkle Severity Rating Scale (WSRS) and the Global Aesthetic Improvement Scale (GAIS). Methods The study enrolled 109 patients in three different centers that were treated with various SFP fillers to treat facial aging. In this post-marketing clinical study, we have evaluated the efficacy of SFP for the treatment of facial aging. Skinfill plus (SFP) belongs to the family of monophasic monodensified fillers. The most commonly used dermal filler is hyaluronic acid. ![]() ![]() Abstract Background Injectable dermal fillers are commonly used by physicians in the treatment of the signs of aging.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |